M LH1 (Hydrochlorothiazide and lisinopril 12.5 mg / 10 mg)
Pill imprint M LH1 has been identified as Hydrochlorothiazide and lisinopril 12.5 mg / 10 mg.
Hydrochlorothiazide/lisinopril is used in the treatment of high blood pressure; heart failure and belongs to the drug class antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/lisinopril 12.5 mg / 10 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for M LH1 (Hydrochlorothiazide and lisinopril 12.5 mg / 10 mg)
- Imprint:
-
M
LH1 - Strength:
- 12.5 mg / 10 mg
- Color:
- White
- Size:
- 9.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Antihypertensive combinations
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-1012
- Inactive Ingredients:
- silicon dioxide
croscarmellose sodium
calcium phosphate dihydrate dibasic
magnesium stearate
mannitol
microcrystalline cellulose
povidone
corn starch
sodium lauryl sulfate
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0697 | UDL Laboratories Inc |
Note: Inactive ingredients may vary.
More resources
Hydrochlorothiazide and lisinopril is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
